AR068850A1 - Soluciones de dialisis que contienen pirofosfatos - Google Patents

Soluciones de dialisis que contienen pirofosfatos

Info

Publication number
AR068850A1
AR068850A1 ARP080104454A ARP080104454A AR068850A1 AR 068850 A1 AR068850 A1 AR 068850A1 AR P080104454 A ARP080104454 A AR P080104454A AR P080104454 A ARP080104454 A AR P080104454A AR 068850 A1 AR068850 A1 AR 068850A1
Authority
AR
Argentina
Prior art keywords
dialysis
dialysis solution
solutions
solutions containing
dialysis solutions
Prior art date
Application number
ARP080104454A
Other languages
English (en)
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of AR068850A1 publication Critical patent/AR068850A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A61M1/1672—Apparatus for preparing dialysates using membrane filters, e.g. for sterilising the dialysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A61M1/1674—Apparatus for preparing dialysates using UV radiation sources for sterilising the dialysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

Soluciones de diálisis que comprenden pirofosfatos y métodos de preparar y usar las soluciones de diálisis. En una realizacion, la presente revelacion proporciona una solucion de diálisis que comprende una cantidad estable y terapéuticamente efectiva de pirofosfato. La solucion de diálisis se puede esterilizar, por ejemplo, usando una técnica tal como autoclave, vapor, presion alta, ultra violeta, filtracion o combinacion de estos. La solucion de diálisis puede presentar la forma de un concentrado. Reivindicacion 1: Una solucion de diálisis esterilizada caracterizada porque comprende un componente de diálisis seleccionado del grupo que consiste de agentes osmoticos, soluciones amortiguadoras, electrolitos y combinaciones de estos y una cantidad terapéuticamente efectiva de pirofosfato.
ARP080104454A 2007-10-11 2008-10-10 Soluciones de dialisis que contienen pirofosfatos AR068850A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/871,018 US7658952B2 (en) 2007-10-11 2007-10-11 Dialysis solutions containing pyrophosphates

Publications (1)

Publication Number Publication Date
AR068850A1 true AR068850A1 (es) 2009-12-09

Family

ID=40111058

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104454A AR068850A1 (es) 2007-10-11 2008-10-10 Soluciones de dialisis que contienen pirofosfatos

Country Status (17)

Country Link
US (2) US7658952B2 (es)
EP (1) EP2211874B1 (es)
JP (1) JP5475671B2 (es)
KR (1) KR101548027B1 (es)
CN (1) CN101820889B (es)
AR (1) AR068850A1 (es)
AU (1) AU2008311054B2 (es)
BR (1) BRPI0818250A2 (es)
CA (1) CA2701763C (es)
CO (1) CO6270333A2 (es)
DK (1) DK2211874T3 (es)
ES (1) ES2450131T3 (es)
HK (1) HK1144548A1 (es)
MX (1) MX2010003930A (es)
PL (1) PL2211874T3 (es)
TW (1) TWI429441B (es)
WO (1) WO2009048849A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
DE102010012282A1 (de) * 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzung enthaltend Cyclodextrin-Copolymer
ES2592938T3 (es) * 2010-04-23 2016-12-02 Baxter International Inc. Procedimientos y composiciones para reducir o evitar la calcificación vascular durante terapia de diálisis peritoneal
CA2830085A1 (en) 2011-03-23 2012-09-27 Nxstage Medical, Inc. Peritoneal dialysis systems, devices, and methods
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
DE102014013885A1 (de) * 2014-09-18 2016-03-24 Fresenius Medical Care Deutschland Gmbh Dialyselösung
CN106581053A (zh) * 2015-10-20 2017-04-26 华仁药业股份有限公司 一种具有补铁功能的腹膜透析液
JP7129757B2 (ja) * 2016-03-31 2022-09-02 旭化成メディカル株式会社 血液浄化装置及び滅菌方法
DE102016124626A1 (de) * 2016-12-16 2018-06-21 B. Braun Avitum Ag Verfahren zur Nach- und Vorbereitung von Therapieabläufen an einer Vorrichtung zur extrakorporalen Blutbehandlung mit kombinierter Desinfektion und Entkalkung mit saurem Konzentrat
US11207454B2 (en) 2018-02-28 2021-12-28 Nxstage Medical, Inc. Fluid preparation and treatment devices methods and systems
CN110314244A (zh) * 2019-07-08 2019-10-11 界首永恩机电科技有限公司 一种冷却液高效灭菌方法
CN114869906A (zh) * 2022-05-18 2022-08-09 华裕(无锡)制药有限公司 一种透析浓缩物及其制备及质量检测方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931396A (en) * 1973-05-31 1976-01-06 Commissariat A L'energie Atomique Method of preparation of a composition having a base of 99m technetium for diagnosis by scintigraphy
JPH0951932A (ja) * 1995-08-16 1997-02-25 Material Eng Tech Lab Inc 腹膜透析液用容器
JP3271650B2 (ja) * 1995-10-26 2002-04-02 清水製薬株式会社 重炭酸イオン含有無菌性配合液剤又は製剤及びその製造方法
DE19631124A1 (de) * 1996-08-01 1998-02-05 Fresenius Medical Care De Gmbh Verfahren zur Herstellung einer Bicarbonat enthaltenden Infusions- oder Dialysierlösung
JP3955639B2 (ja) * 1996-12-31 2007-08-08 グプタ，アジャイ 血液透析及び腹膜透析患者における鉄デリバリーのための方法及び医薬組成物
US6689275B1 (en) * 1996-12-31 2004-02-10 Ajay Gupta Method and pharmaceutical composition for replacing iron losses in dialysis patients
US6779468B1 (en) * 1997-08-07 2004-08-24 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
US6537976B1 (en) * 1997-08-07 2003-03-25 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
US6309673B1 (en) * 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
GB0001172D0 (en) * 2000-01-20 2000-03-08 Res Del International Limited Physiological medium for perfusing, preserving and storing isolated cell tissue and organ samples
AU2004287440A1 (en) * 2003-10-28 2005-05-19 Emory University Dialysates and methods and systems related thereto
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
EP1796683A1 (en) 2004-07-15 2007-06-20 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US7857977B2 (en) * 2005-07-12 2010-12-28 Rockwell Medical Technologies, Inc. Packaging of ferric pyrophosphate for dialysis
EP1909737A1 (en) * 2005-08-02 2008-04-16 Baxter International Inc. Medical products and parenteral formulations
BRPI0620425B8 (pt) * 2005-12-23 2021-06-22 Gupta Ajay composição para nutrição parenteral, método para preparar a mesma, uso, e, kit
ES2580127T3 (es) 2006-01-30 2016-08-19 Panion & Bf Biotech Inc. Procedimiento de tratamiento de la nefropatía crónica
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates

Also Published As

Publication number Publication date
AU2008311054B2 (en) 2012-10-18
AU2008311054A1 (en) 2009-04-16
KR20100075525A (ko) 2010-07-02
TWI429441B (zh) 2014-03-11
CO6270333A2 (es) 2011-04-20
ES2450131T3 (es) 2014-03-24
CN101820889A (zh) 2010-09-01
JP5475671B2 (ja) 2014-04-16
KR101548027B1 (ko) 2015-08-27
TW200924783A (en) 2009-06-16
MX2010003930A (es) 2010-05-24
EP2211874B1 (en) 2013-12-11
US7658952B2 (en) 2010-02-09
CA2701763C (en) 2017-04-18
HK1144548A1 (en) 2011-02-25
CN101820889B (zh) 2014-03-26
WO2009048849A1 (en) 2009-04-16
US20090098215A1 (en) 2009-04-16
CA2701763A1 (en) 2009-04-16
PL2211874T3 (pl) 2014-05-30
EP2211874A1 (en) 2010-08-04
BRPI0818250A2 (pt) 2015-04-07
US8273378B2 (en) 2012-09-25
JP2011500578A (ja) 2011-01-06
US20100119618A1 (en) 2010-05-13
DK2211874T3 (en) 2014-02-17

Similar Documents

Publication Publication Date Title
AR068850A1 (es) Soluciones de dialisis que contienen pirofosfatos
CY1118105T1 (el) Αγγειογενεση χρησιμοποιωντας πλακουντιακα βλαστικα κυτταρα
CO2017004715A2 (es) Métodos y formulaciones para tratar enfermedades vasculares de los ojos
ES2537539T3 (es) Composición oftálmica
ATE540327T1 (de) Kontaktlinsenverpackungslösungen
BR112016024454A2 (pt) solução oftálmica aquosa e método para o tratamento da síndrome do olho seco
UY31816A (es) Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras
MX352745B (es) Soluciones estabilizadas de acido hipohaloso.
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
AR084567A1 (es) Implante con calcio en su superficie y metodos de modificacion de la superficie de un implante para dotar a dicha superficie de calcio
CL2011001306A1 (es) Composicion antimicrobiana que comprende una sal de plata soluble, una alcanolamida, y/o aminoalcohol, un ph 6 o superior; composicion limpiadora que comprende un surfactante, una sal de plata soluble, una alcanolamida, y/o aminoalcohol.
SV2016005265A (es) Proceso para producir una solución inyectable de noradrenalina de baja concentración, estable
WO2015061632A3 (en) Antimicrobial compositions and articles
CO6640334A2 (es) Composiciones transparentes de limpieza de baja irritabilidad con ph relativamente bajo
MX2016013134A (es) Proceso para descontaminar o esterilizar un articulo con composicion que contiene peroxido y agente antimicrobiano.
MX2019007572A (es) Composiciones que comprenden acido acetico y acido hipocloroso y metodos para tratar biopelicula.
CL2009001077A1 (es) Vehiculo particulado polimerico que comprende un agente biologico en fase acuosa en un lumen hueco; procedimiento para suministrar una proteina en el ojo; composicion farmaceutica que comprende dicho vehiculo; y su uso para profilaxis y tratar enfermedades o trastornos del ojo.
AR095681A2 (es) Una solución acuosa desinfectante no terapéutica, un método para prepararla, una preparación desinfectante y un método para desinfectar o esterilizar un objeto
HRP20120778T1 (hr) Mehaniäśka dezinfekcija predmeta
AR091977A1 (es) El uso de antitrombina en la oxigenacion de membranas extracorporeas
CL2011002926A1 (es) Solucion farmaceutica que tiene un ph de 10 o superior, que contiene telmisartan en concentracion de 1 a 10mg/ml y uno o mas azucar-alcoholes en concentracion de 40-70% (de preferencia 60-70%); metodo de preparacion; uso para el tratamiento de la hipertension o lesiones renales; y recipiente de vidrio o plastico que la contiene.
AR073967A1 (es) Peptido-epitope rab6kifl/kif20a y vacunas que contienen al mismo
MX2021007342A (es) Indicador biologico para sistema de esterilizacion quimico-liquido.
MX2014015513A (es) Metodo y sistema para uso de peroxido de hidrogeno y luz ultravioleta para desinfeccion y sanitizacion de huevo.
MY176564A (en) Kit and method for cleaning and disinfecting medical instruments and appliances

Legal Events

Date Code Title Description
FB Suspension of granting procedure